134 related articles for article (PubMed ID: 17415108)
41. [The role of colposcopy, today].
Mossetti C
Minerva Ginecol; 1986 Dec; 38(12):975-7. PubMed ID: 3808447
[No Abstract] [Full Text] [Related]
42. [Differential diagnosis of precancerous and cancerous states of the cervix uteri based on the multiparameter analysis of the results of cytological studies].
Petrova AS; Isakova LM; Isakov VL
Arkh Patol; 1984; 46(8):13-7. PubMed ID: 6497694
[TBL] [Abstract][Full Text] [Related]
43. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
[TBL] [Abstract][Full Text] [Related]
44. Antibody anti-p16(INK4a) in cervical cytology.
Kane S; Ajit D; Gavas S
Acta Cytol; 2010; 54(5 Suppl):1071-2; author reply 1072-3. PubMed ID: 21053608
[No Abstract] [Full Text] [Related]
45. [Value of contact fluorescent colpomicroscopy in the diagnosis of pathological processes of the cervix uteri].
Garmanova NV; Bokhman IaV; Drulia EM
Akush Ginekol (Mosk); 1987 Jul; (7):37-41. PubMed ID: 3688328
[No Abstract] [Full Text] [Related]
46. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
47. [Detection of p16 in precancerous lesions of the cervix uteri].
Bergeron C
Ann Pathol; 2010 Nov; 30(5 Suppl 1):105-6. PubMed ID: 21055562
[No Abstract] [Full Text] [Related]
48. Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum.
Kong CS; Welton ML; Longacre TA
Am J Surg Pathol; 2007 Jun; 31(6):919-25. PubMed ID: 17527081
[TBL] [Abstract][Full Text] [Related]
49. Assessment of new technologies for cervical cancer screening.
Villa LL
Lancet Oncol; 2008 Oct; 9(10):910-1. PubMed ID: 19071241
[No Abstract] [Full Text] [Related]
50. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
Zhao C; Austin RM
Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
[TBL] [Abstract][Full Text] [Related]
51. Cell cycle dysregulation influences survival in high risk breast cancer patients.
Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
[TBL] [Abstract][Full Text] [Related]
52. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
53. High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions.
Laco J; Slaninka I; Jirásek M; Celakovský P; Vosmiková H; Ryska A
Pathol Res Pract; 2008; 204(8):545-52. PubMed ID: 18440161
[TBL] [Abstract][Full Text] [Related]
54. Cervical cancer screening.
Bren L
FDA Consum; 2004; 38(1):36-7. PubMed ID: 15032203
[No Abstract] [Full Text] [Related]
55. [Behavior of SCC marker level in cervix erosion, cervix dysplasia and cervical pre-invasive carcinoma].
Uzar A; Rzepka-Górska I; Kosmowska B
Ginekol Pol; 1992 Jan; 63(1):10-4. PubMed ID: 1304503
[TBL] [Abstract][Full Text] [Related]
56. Molecular markers: how to apply in practice.
von Knebel-Doeberitz M; Syrjänen KJ
Gynecol Oncol; 2006 Oct; 103(1):18-20. PubMed ID: 16919709
[No Abstract] [Full Text] [Related]
57. [Basement membranes in precancerous conditions and neoplasms of the uterine cervix].
Murav'ev GN
Vopr Onkol; 1979; 25(9):27-32. PubMed ID: 483715
[TBL] [Abstract][Full Text] [Related]
58. [Prevention of cervical cancer. Guidelines].
Collège National des Gynécologues et Obstétriciens Français
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S167-72. PubMed ID: 18409213
[No Abstract] [Full Text] [Related]
59. [Diagnosis and therapy of precancerous lesions of the uterine cervix].
Remotti G; De Virgiliis G; Ferrari A
Ann Ostet Ginecol Med Perinat; 1982; 103(3):179-84. PubMed ID: 7137766
[No Abstract] [Full Text] [Related]
60. Precursor lesions of squamous cell carcinoma of the cervix: are there reliable predictors of biologic behavior?
Gorstein F
Hum Pathol; 2000 Nov; 31(11):1339-40. PubMed ID: 11112206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
